A study examining placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFLT-1), and VEGF-A highlighted their involvement in cardiorenal complications in patients with T2DM [314]. This evidence concerns the gene PGF and type 2 diabetes mellitus.